Synopsis
Synopsis
0
CEP/COS
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
1. Hsr 803
2. Hsr-803
3. N-(4-(2-(dimethylamino)ethoxy)benzyl)-3,4-dimethoxybenzmide
1. 122892-31-3
2. Itopride Hcl
3. Ganaton
4. Itopride (hydrochloride)
5. Hsr803
6. Hsr-803
7. Itax
8. Hsr 803
9. Benzamide, N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4-dimethoxy-, Hydrochloride (1:1)
10. 2h9nv66w0i
11. N-(4-(2-(dimethylamino)ethoxy)benzyl)-3,4-dimethoxybenzamide Hydrochloride
12. N-[4-(2-dimethylaminoethoxy)benzyl]-3,4-dimethoxybenzamide Hcl
13. 122892-31-3 (hcl)
14. Benzamide, N-((4-(2-(dimethylamino)ethoxy)phenyl)methyl)-3,4-dimethoxy-, Monohydrochloride
15. Dsstox_cid_26693
16. Dsstox_rid_81827
17. Dsstox_gsid_46693
18. Itopride Hydrochloride (jan)
19. Itopride Hydrochloride [jan]
20. Cas-122892-31-3
21. Ncgc00167529-01
22. Unii-2h9nv66w0i
23. N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4-dimethoxybenzamide Hydrochloride
24. Ganaton (tn)
25. Mfcd00881710
26. N-(4-(2-(dimethylamino)ethoxy)benzyl)-3,4-dimethoxidebenzamide Hydrochloride
27. N-((4-(2-(dimethylamino)ethoxy)phenyl)methyl)-3,4-dimethoxybenzamide Monohydrochloride
28. Mls001401433
29. Schembl554675
30. Chembl2139257
31. Dtxsid5046693
32. N-(4-(2-(dimethylamino)ethoxy)benzyl)-3,4-dimethoxybenzmide
33. Itopride Hydrochloride [mi]
34. Amy18457
35. Bcp12149
36. Hy-b0732
37. Tox21_112526
38. S4619
39. Akos007930375
40. Itopride Hydrochloride [mart.]
41. N-[4-(2-dimethylaminoethoxy)benzyl]-3,4-dimethoxybenzamide Hydrochloride
42. Tox21_112526_1
43. Ab07646
44. Ccg-101047
45. Itopride Hydrochloride [who-dd]
46. Ks-5067
47. Nc00297
48. Itopride Hydrochloride, >=98% (hplc)
49. Ncgc00167529-02
50. Ac-32564
51. Smr000469143
52. Ft-0631110
53. I0948
54. D02729
55. 892i313
56. A804984
57. Q-201260
58. Q27254746
59. N-{p-[2-(dimethylamino)ethoxy]benzyl}veratramide Hydrochloride
60. N-((4-(2-(dimethylamino)ethoxy)phenyl)methyl)-3,4-dimethoxy-benzamidmonohydrochloride
61. N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4-dimethoxybenzamide;hydrochloride
| Molecular Weight | 394.9 g/mol |
|---|---|
| Molecular Formula | C20H27ClN2O4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 9 |
| Exact Mass | 394.1659350 g/mol |
| Monoisotopic Mass | 394.1659350 g/mol |
| Topological Polar Surface Area | 60 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 411 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ANALYTICAL
ABOUT THIS PAGE
64
PharmaCompass offers a list of Itopride Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Itopride Hydrochloride manufacturer or Itopride Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Itopride Hydrochloride manufacturer or Itopride Hydrochloride supplier.
PharmaCompass also assists you with knowing the Itopride Hydrochloride API Price utilized in the formulation of products. Itopride Hydrochloride API Price is not always fixed or binding as the Itopride Hydrochloride Price is obtained through a variety of data sources. The Itopride Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Itopride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Itopride, including repackagers and relabelers. The FDA regulates Itopride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Itopride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Itopride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Itopride supplier is an individual or a company that provides Itopride active pharmaceutical ingredient (API) or Itopride finished formulations upon request. The Itopride suppliers may include Itopride API manufacturers, exporters, distributors and traders.
click here to find a list of Itopride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Itopride DMF (Drug Master File) is a document detailing the whole manufacturing process of Itopride active pharmaceutical ingredient (API) in detail. Different forms of Itopride DMFs exist exist since differing nations have different regulations, such as Itopride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Itopride DMF submitted to regulatory agencies in the US is known as a USDMF. Itopride USDMF includes data on Itopride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Itopride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Itopride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Itopride Drug Master File in Japan (Itopride JDMF) empowers Itopride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Itopride JDMF during the approval evaluation for pharmaceutical products. At the time of Itopride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Itopride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Itopride Drug Master File in Korea (Itopride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Itopride. The MFDS reviews the Itopride KDMF as part of the drug registration process and uses the information provided in the Itopride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Itopride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Itopride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Itopride suppliers with KDMF on PharmaCompass.
A Itopride written confirmation (Itopride WC) is an official document issued by a regulatory agency to a Itopride manufacturer, verifying that the manufacturing facility of a Itopride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Itopride APIs or Itopride finished pharmaceutical products to another nation, regulatory agencies frequently require a Itopride WC (written confirmation) as part of the regulatory process.
click here to find a list of Itopride suppliers with Written Confirmation (WC) on PharmaCompass.
Itopride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Itopride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Itopride GMP manufacturer or Itopride GMP API supplier for your needs.
A Itopride CoA (Certificate of Analysis) is a formal document that attests to Itopride's compliance with Itopride specifications and serves as a tool for batch-level quality control.
Itopride CoA mostly includes findings from lab analyses of a specific batch. For each Itopride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Itopride may be tested according to a variety of international standards, such as European Pharmacopoeia (Itopride EP), Itopride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Itopride USP).
